Arecor Therapeutics PLC
LSE:AREC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Arecor Therapeutics PLC (AREC) under the Base Case is GBX per share. Compared with the current market price of 77.5 GBX, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Arecor Therapeutics Does
Arecor Therapeutics is a drug formulation company. It does not make and sell a broad range of medicines itself; instead, it develops ways to improve how existing drugs are formulated, stored, and delivered, especially injectable medicines such as insulin and other biologics. Its work focuses on making treatments more stable, easier to use, and better suited to real-world patient care.
- Headquarters
- United Kingdom UK
- Employees
- 33
- IPO date
- Jun 3, 2021
Earnings Waterfall
Arecor Therapeutics PLC
What is the Intrinsic Value of one AREC stock?
The intrinsic value for Arecor Therapeutics PLC (AREC) under the Base Case is GBX.
Is AREC stock undervalued or overvalued?
Compared with the current market price of 77.5 GBX, the stock appears .